Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques (Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, SMBG, POCT), Applications (Infectious, Cardiovascular Diseases), End User, Companies

Abstract
In-Vitro Diagnostic tests provide adequate information about the diseases without interacting directly to the human body. In-Vitro Diagnostic has numerous applications in disease diagnosing such as Infectious diseases, Oncology, Diabetes, Cardiovascular diseases, and others. IVD is used by physicians and clinicians at the various stages of the patient care pathway in hospitals, laboratories or other healthcare settings. With the increasing disease burden, the number of diagnostic tests in Saudi Arabia is also increasing and so is the In Vitro Diagnostics market of Saudi Arabia. Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024.

With increasing cases of new strains of viruses and epidemic diseases, health experts are innovating unique healthcare solutions to improve the combat and cure for diseases. Among these innovations, In-vitro diagnostics plays a considerable role in saving people's lives by providing accurate diagnosis and prognosis, which further enables improved monitoring and treatment. Owing to the benefits offered by IVD, there is steady growth in its adoption and usage. Increasing incidences rates of infectious diseases and the lifestyle diseases are few factors, which are driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market.

Renub Research report titled “Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques [Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT)]; by Applications (Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes and others); By End User (Government Labs & Hospitals, Private Labs & Hospitals and others) and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)” provides a complete analysis of Saudi Arabia In-Vitro Diagnostics (IVD) Market.

By Technique – Immunochemistry, Clinical Chemistry and SMBG Driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market
The report studies the market of the following In-Vitro Diagnostics segments: Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT). Due to the rising infectious diseases, cancer cases and number of diabetics in the Kingdom of Saudi Arabia, it is believed that Saudi Arabia IVD Market will grow effortlessly in the coming years.

By Application – Infectious Disease and Diabetes hold significant market of Saudi Arabia In-Vitro Diagnostics (IVD) Market
On the basis of applications; Saudi Arabia In-Vitro Diagnostics has been broadly segmented into Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes and others.

By End User – Government Hospitals & Laboratory holds the Largest Market
The report studies the market of the following End User segments: Government Labs & Hospitals, Private Labs & Hospitals and others.

Companies Analysis
Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation are some of the top companies operating in the In-Vitro Diagnostics; has been studied thoroughly in the report.

This market research report provides a complete analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market, Growth Drivers, Challenges, and their projections for the upcoming years.

By Technique
• Immunochemistry
• Clinical Chemistry
• Hematology
• Hemostasis
• Microbiology
• Molecular Diagnostic
• Self Monitoring of Blood Glucose (SMBG)
• Point of Care Testing (POCT)

By Application
• Infectious Diseases
• Cardiovascular Diseases
• Diabetes
• Oncology
• Others

By End User
• Government Labs & Hospitals
• Private Labs & Hospitals
• Others

Company
• Roche
• Abbott
• Siemens Healthineers
• Sysmex Corporation
• Danaher Corporation

Content
Table of Contents

1. Introduction
2. Research Methodology
3. Executive Summary
4. Saudi Arabia
4.1 Population
4.2 Per Capita Healthcare Expenses
4.3 Healthcare Expenditure
5. Saudi Arabia IVD Market (2011–2024)
6. Market Share – Saudi Arabia In Vitro Diagnostics (IVD) (2011 – 2024)
6.1 By Segments
6.2 By Disease
7. Segments – Saudi Arabia IVD Market (2011– 2024)
7.1 Immunochemistry Market
7.2 Clinical Chemistry Market
7.3 Hematology Market
7.4 Hemostasis/Coagulation Market
7.5 Microbiology Market
7.6 Molecular Diagnostic Market
7.7 Self Monitoring of Blood Glucose (SMBG) Market
7.8 Point of Care Testing (POCT) Market
8. Disease - Saudi Arabia IVD Market (2011– 2024)
8.1 Infectious
8.2 Cardiovascular
8.3 Diabetes
8.4 Oncology
8.5 Others
9. End User – Saudi Arabia IVD Market (2011– 2024)
9.1 Public Labs & Hospitals
9.2 Private Labs & Hospitals
10. Company Analysis
10.1 Roche Diagnostics
10.1.1 Overview
10.1.2 Company Initiatives
10.1.3 Sales Analysis
10.2 Abbott
10.2.1 Overview
10.2.2 Company Initiatives
10.2.3 Sales Analysis
10.3 Siemens Healthineers
10.3.1 Overview
10.3.2 Company Initiatives
10.3.3 Sales Analysis
10.4 Sysmex Corporation
10.4.1 Overview
10.4.2 Company Initiatives
10.4.3 Sales Analysis
10.5 Danaher Corporation
10.5.1 Overview
10.5.2 Company Initiatives
10.5.3 Sales Analysis

List of Figures:
Figure-01: Saudi Arabia – IVD Market size (Million US$), 2018 & 2024
Figure-02: Saudi Arabia – IVD Market by Growing Diseases
Figure-03: Saudi Arabia Population (Million), 2011 – 2018
Figure-04: Forecast for Saudi Arabia Population (Million), 2019 – 2024
Figure-05: Saudi Arabia Per Capita Healthcare Expenses, 2011 – 2017
Figure-06: Saudi Arabia Healthcare Expenditure (Billion US$) , 2011 – 2017
Figure-07: Saudi Arabia IVD Market (Million US$), 2011 – 2018
Figure-08: Forecast for Saudi Arabia IVD Market (Million US$), 2019 – 2024
Figure-09: Saudi Arabia IVD Market Share by Segments (Percent), 2011 – 2018
Figure-10: Forecast for Saudi Arabia IVD Market Share by Segments (Percent), 2011 – 2018
Figure-11: Saudi Arabia – Immunochemistry Market (Million US$), 2011 – 2018
Figure-12: Saudi Arabia – Forecast for Immunochemistry Market (Million US$), 2019 – 2024
Figure-13: Saudi Arabia – Clinical Chemistry Market (Million US$), 2011 – 2018
Figure-14: Saudi Arabia – Forecast for Clinical Chemistry Market (Million US$), 2019 – 2024
Figure-15: Saudi Arabia – Hematology Market (Million US$), 2011 – 2018
Figure-16: Saudi Arabia – Forecast for Hematology Market (Million US$), 2019 – 2024
Figure-17: Saudi Arabia – Hemostasis/Coagulation Market (Million US$), 2011 – 2018
Figure-18: Saudi Arabia – Forecast for Hemostasis/Coagulation Market (Million US$), 2019 – 2024
Figure-19: Saudi Arabia – Microbiology Market (Million US$), 2011 – 2018
Figure-20: Saudi Arabia – Forecast for Microbiology Market (Million US$), 2019 – 2024
Figure-21: Saudi Arabia – Molecular Diagnostic Market (Million US$), 2011 – 2018
Figure-22: Saudi Arabia – Forecast for Molecular Diagnostic Market (Million US$), 2019 – 2024
Figure-23: Saudi Arabia – Self Monitoring of Blood Glucose (SMBG) Market (Million US$), 2011 – 2018
Figure-24: Saudi Arabia – Forecast for Self Monitoring of Blood Glucose (SMBG) Market (Million US$), 2019 – 2024
Figure-25: Saudi Arabia – Point of Care Testing (POCT) Market (Million US$), 2011 – 2018
Figure-26: Saudi Arabia – Forecast for Point of Care Testing (POCT) Market (Million US$), 2019 – 2024
Figure-27: Saudi Arabia – Infectious Disease Market (Million US$), 2011 – 2018
Figure-28: Saudi Arabia - Forecast for Infectious Disease Market (Million US$), 2019 – 2024
Figure-29: Saudi Arabia – Cardiovascular Disease Market (Million US$), 2011 – 2018
Figure-30: Saudi Arabia – Forecast for Cardiovascular Disease Market (Million US$), 2019 – 2024
Figure-31: Saudi Arabia – Diabetes Market (Million US$), 2011 – 2018
Figure-32: Saudi Arabia – Forecast for Diabetes Market (Million US$), 2019 – 2024
Figure-33: Saudi Arabia – Oncology Market (Million US$), 2011 – 2018
Figure-34: Saudi Arabia – Forecast for Oncology Market (Million US$), 2019 – 2024
Figure-35: Saudi Arabia – Other Disease Market (Million US$), 2011 – 2018
Figure-36: Saudi Arabia – Forecast for Other Disease Market (Million US$), 2019 – 2024
Figure-37: Saudi Arabia – End User Market by Public Labs (Million US$), 2011 – 2018
Figure-38: Saudi Arabia – Forecast for End User Market by Public Labs (Million US$), 2019 – 2024
Figure-39: Saudi Arabia – End User Market by Private Labs (Million US$), 2011 – 2018
Figure-40: Saudi Arabia – Forecast for End User Market by Private Labs (Million US$), 2019 – 2024
Figure-41: Saudi Arabia – End User Market by Other Labs (Million US$), 2011 – 2018
Figure-42: Saudi Arabia – Forecast for End User Market by Other Labs (Million US$), 2019 – 2024
Figure-43: KSA Insurance Market (in SAR Million) 2007 - 2015
Figure-44: Total Population in KSA in Million
Figure-45: Percentage share of Population over 60 years old
Figure-46: Countries with Highest Hypertension Prevalence Rate in MENA Regions (2014)
Figure-47: Countries with Highest Diabetes Prevalence Rate in MENA Region (2014)
Figure-48: Rising Cigar Import – 2010 - 2013
Figure-49: Percentage Split of Healthcare services in KSA 2014
Figure-50: Percentage Split of Laboratory services in KSA 2014
Figure-51: Roche Diagnostics – Global Sales (Billion US$), 2011 - 2018
Figure-52: Roche Diagnostics – Global Sales Forecast (Billion US$), 2019 - 2024
Figure-53: Abbott – Global Diagnostics Sales (Million US$), 2011 - 2018
Figure-54: Abbott – Forecast Global Diagnostics Sales (Million US$), 2019 - 2024
Figure-55: Siemens Healthineers – Net Sales (Million US$), 2011 - 2018
Figure-56: Siemens Healthineers – Forecast for Net Sales (Million US$), 2019 - 2024
Figure-57: Sysmex Corporation – Net Sales (Million US$), 2011 - 2018
Figure-58: Sysmex Corporation – Forecast for Net Sales (Million US$), 2019 - 2024
Figure-59: Danaher Corporation – Global Diagnostics Sales (Million US$), 2011 - 2018
Figure-60: Danaher Corporation – Forecast Global Diagnostics Sales (Million US$), 2019 - 2024